31161598|t|Antiproliferative Effect of Elastin-Derived Peptide VGVAPG on SH-SY5Y Neuroblastoma Cells.
31161598|a|Throughout the lifetime of humans, the amount of stem cells and the rate of cell proliferation continue to decrease. Reactive oxygen species (ROS) are one among the many factors that promote stem cell aging. Both a decrease in the level of stem cells and increase in ROS production can lead to the development of different neurodegenerative diseases. This study was conducted to determine how the VGVAPG peptide, liberated from elastin during the aging process and under pathological conditions, affects ROS production and activities of antioxidant enzymes in undifferentiated, proliferating SH-SY5Y cells. SH-SY5Y cells were maintained in Dulbecco's modified Eagle's medium/nutrient mixture F-12 supplemented with 10% heat-inactivated fetal bovine serum (FBS). After treating the SH-SY5Y cells with VGVAPG peptide, we measured ROS production; cell metabolism, proliferation, and expression; and activities of superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT). We demonstrated that the VGVAPG peptide increases GPx expression and activity, whereas it decreases CAT expression in SH-SY5Y cells. Silencing of the GLB1 gene prevents changes in GPx activity. Despite the fact that the VGVAPG peptide increases GPx expression, it increases the ROS level. Moreover, the VGVAPG peptide decreases SH-SY5Y proliferation, which is prevented by the ROS scavenger N-acetyl-L-cysteine. Our data suggest that ROS production and decreased proliferation of SH-SY5Y cells are the results of excitotoxicity meditated through close unrecognized molecular pathways. More research is needed to elucidate the unknown mechanism of action of VGVAPG peptide in the nervous system.
31161598	28	35	Elastin	Gene	2006
31161598	52	58	VGVAPG	Chemical	MESH:C042635
31161598	62	69	SH-SY5Y	CellLine	CVCL:0019
31161598	70	83	Neuroblastoma	Disease	MESH:D009447
31161598	118	124	humans	Species	9606
31161598	208	231	Reactive oxygen species	Chemical	MESH:D017382
31161598	233	236	ROS	Chemical	MESH:D017382
31161598	358	361	ROS	Chemical	MESH:D017382
31161598	414	440	neurodegenerative diseases	Disease	MESH:D019636
31161598	488	502	VGVAPG peptide	Chemical	-
31161598	519	526	elastin	Gene	2006
31161598	595	598	ROS	Chemical	MESH:D017382
31161598	683	690	SH-SY5Y	CellLine	CVCL:0019
31161598	698	705	SH-SY5Y	CellLine	CVCL:0019
31161598	731	765	Dulbecco's modified Eagle's medium	Chemical	-
31161598	783	787	F-12	Chemical	MESH:C007782
31161598	872	879	SH-SY5Y	CellLine	CVCL:0019
31161598	891	905	VGVAPG peptide	Chemical	-
31161598	919	922	ROS	Chemical	MESH:D017382
31161598	1001	1021	superoxide dismutase	Gene	6647
31161598	1023	1026	SOD	Gene	6647
31161598	1063	1071	catalase	Gene	847
31161598	1073	1076	CAT	Gene	847
31161598	1104	1118	VGVAPG peptide	Chemical	-
31161598	1179	1182	CAT	Gene	847
31161598	1197	1204	SH-SY5Y	CellLine	CVCL:0019
31161598	1229	1233	GLB1	Gene	2720
31161598	1299	1313	VGVAPG peptide	Chemical	-
31161598	1357	1360	ROS	Chemical	MESH:D017382
31161598	1382	1396	VGVAPG peptide	Chemical	-
31161598	1407	1414	SH-SY5Y	CellLine	CVCL:0019
31161598	1456	1459	ROS	Chemical	MESH:D017382
31161598	1470	1489	N-acetyl-L-cysteine	Chemical	MESH:D000111
31161598	1513	1516	ROS	Chemical	MESH:D017382
31161598	1559	1566	SH-SY5Y	CellLine	CVCL:0019
31161598	1592	1606	excitotoxicity	Disease	
31161598	1736	1750	VGVAPG peptide	Chemical	-
31161598	Negative_Correlation	MESH:D000111	MESH:D017382
31161598	Association	MESH:C042635	2006
31161598	Negative_Correlation	MESH:C042635	MESH:D009447
31161598	Association	MESH:D009447	2006
31161598	Positive_Correlation	MESH:D017382	MESH:D019636

